Reuters: Vertex says cystic fibrosis drugs shown to boost lung function

(Reuters) - Vertex Pharmaceuticals Inc on Thursday said a combination of its cystic fibrosis drug Kalydeco and an experimental compound was shown to improve lung function in a mid-stage trial, sending its shares up nearly 8 percent. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/wOCUd5lx4l8/story01.htm

Read More